Location History:
- Kunming, CN (2019)
- Yunnan, CN (2014 - 2020)
Company Filing History:
2 out of 321 
1 out of 1,244 
1 out of 47 
Years Active: 2014-2020
Title: Innovations by Wan Yi Li in Pharmaceutical Composition
Introduction
Wan Yi Li is an accomplished inventor based in Yunnan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic obstructive pulmonary disease (COPD) and neuroinflammation. With a total of 3 patents, his work focuses on developing compositions that are both effective and safe for patients.
Latest Patents
One of his latest patents is a pharmaceutical composition aimed at preventing or treating chronic obstructive pulmonary disease (COPD). This invention includes aextract, a fraction thereof, or a compound isolated from the same. The composition is designed to suppress the invasion of inflammatory cells into the bronchial tubes of COPD-induced animal models. It effectively reduces the expression of inflammatory markers such as CXCL-1, TNF-α, and MIP-2. Additionally, the use of a safety-proven herbal drug as a raw material helps to mitigate the side effects associated with existing therapeutic agents for COPD and related conditions.
Another notable patent involves a method for treating neuroinflammation using a pharmaceutical composition containing Hook. extract or a fraction thereof as an active ingredient. This composition is intended for preventing, treating, or ameliorating neuroinflammation or neuro-degenerative diseases. The natural product used in this invention has been recognized for its medicinal properties and is free from side effects. It inhibits the expression of genes associated with inflammation and has shown effectiveness in enhancing memory and learning abilities.
Career Highlights
Wan Yi Li has worked with prestigious institutions such as the Korea Research Institute of Bioscience and Biotechnology and Sungkyunkwan University. His research has significantly advanced the understanding and treatment of complex health issues.
Collaborations
He has collaborated with notable colleagues, including Hang Jin and Sei Ryang Oh, who have contributed to his research endeavors.
Conclusion
Wan Yi Li's innovative work in pharmaceutical compositions demonstrates his commitment to improving health outcomes for patients suffering from chronic diseases. His contributions are paving the way for safer and more effective treatments in the medical field.